Adicet Bio, Inc. Shareholders' Equity
Adicet Bio, Inc. (ACET) had Shareholders' Equity of $120.14 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $120.14M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $140.06M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $159.21M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $109.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $120.14M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $140.06M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $159.21M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $109.14M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $133.37M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $161.45M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $186.61M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $211.53M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $235.11M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $258.80M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $170.18M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $194.68M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $239.06M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $266.21M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $292.34M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $317.66M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $293.27M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $311.08M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $303.13M 10-K · filed 2024-03-19 | |
| 2021-09-30 | $217.22M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $228.34M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $236.26M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $109.83M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $116.93M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$72.43M 10-Q · filed 2021-11-10 | $70.74M 10-Q · filed 2020-07-30 |
| 2020-03-31 | -$64.53M 10-Q · filed 2021-11-10 | $75.62M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$60.37M 10-K · filed 2022-03-15 | $81.70M 10-K · filed 2020-03-12 |
| 2019-09-30 | -$54.13M 10-Q · filed 2020-11-05 | $109.76M 10-Q · filed 2019-11-05 |
| 2019-06-30 | -$39.74M 10-Q · filed 2020-11-05 | $126.94M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$37.32M 10-Q · filed 2020-11-05 | $140.46M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$33.52M 10-K · filed 2021-03-12 | $104.20M 10-K · filed 2019-03-18 |
| 2018-09-30 | $109.34M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $117.16M 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $130.38M 10-Q · filed 2019-11-05 | |
| 2017-12-31 | -$26.95M 10-K · filed 2021-03-12 | -$31.93M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $0.00 10-K · filed 2020-03-12 | |
| 2016-07-04 | $0.00 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |